Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee for Loomis’ Annual General Meeting 2023

The following representatives of Loomis AB’s shareholders will be members of the Nomination Committee for the Annual General Meeting 2023:   -        Elisabet Jamal Bergström, appointed by SEB Investment Management, Chairman of the Nomination Committee -        Bernard Horn, appointed by Polaris Capital Management, LLC -        Jacob Lundgren, appointed by Andra AP-fonden -        Elena Herrero, appointed by Indecap Fonder   The Chairman of the Board, Alf Göransson, has convened the Nomination Committee to its first meeting and has also been co-opted to the Nomination

BioStock Investor Meeting: Interview with Elicera Therapeutics

Elicera Therapeutics, led by CEO Jamal El-Mosleh, is developing immuno-oncology drug candidates based primarily on oncolytic viruses and CAR T-cells. The product portfolio includes four drug candidates and the company has also developed the technology platform iTANK. BioStock interviewed El-Mosleh about Elicera’s work at the BioStock Investor Meeting in Stockholm.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-elicera-therapeutics/This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Major investment in food and beverages at Stockholm Arlanda and Göteborg Landvetter – some 20 brand-new restaurants, bars and cafés to open starting in 2023

Swedavia continues to develop its range of services at Stockholm Arlanda Airport and Göteborg Landvetter Airport. The new marketplace at Arlanda will open starting in 2023 and is one of the biggest investments ever in food and beverage outlets at the airport. With the investment, Swedavia’s partner SSP will launch some 20 well-known food and beverage concepts that are brand-new to the airports. Other operators are expected to gradually set up additional food and beverage concepts. All of the concepts that SSP is launching are brand-new to the airports, and many of them will be part of

Alelion receives largest order to date – worth approximately MSEK 130

Alelion has received a major order for high-voltage battery systems from an existing European customer. The order, which is in EUR, with a total value of MSEK 130, will be delivered during Q1 – Q4 in 2023.“With this order, Alelion reach a higher utilization of its production capacity and it allows the company to implement more far-sighted plans regarding improved sourcing and tied capital efficiency”, says Åsa Nordström, CEO at Alelion. “With this order, Alelion secures its position in 2023 as a major supplier of lithium-Ion battery systems,” says Anders Dison, Director Marketing & Sales

First Episealer® Talus surgery performed in Israel

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Israel with the ankle implant Episealer® Talus was successfully performed last week. Dr. Ezequiel Palmanovich performed the surgery at Meir Medical Center, assisted by Prof. Niek van Dijk with support from Episurf. Since previously, the Episealer® Knee technology is available in Israel. “We are pleased with adding an additional market as this was the first Episealer® Talus surgery in Israel“, says Pål Ryfors, CEO Episurf Medical. Prof. Niek van Dijk and the surgical team at Meir Medical Center,

Senior executives sell shares to finance the acquisition of shares through call options

Four senior executives are selling a total of 990 000 shares in MilDef Group. The sale is being made to finance the same persons’ acquisition of major shareholdings in the company based on previously issued call options.The senior executives are MilDef's CEO Björn Karlsson, CFO Daniel Ljunggren, Chief Sales Officer Fredrik Jacobsson, and the company's CTO Fredrik Persson. The transactions further strengthen MilDef's management's long-term ownership in MilDef with more extensive holdings and a larger number of senior executives with substantial ownership in the company. A number of

Cloetta updates on greenfield investment and confirms ambition to propose continued stable dividend

During today’s investor event, management will give an update on the plan to invest in a new greenfield facility in the Netherlands and close three existing plants. In addition to the previously communicated  annual EBIT delivery, Cloetta has quantified the value of enabled insourcing and long-term growth, as well as the net increase of capex as a result of the greenfield investment. Financing has been committed by Cloetta’s existing

BioStock Intestor Meeting: Interview with Redwood Pharma

Stockholmbased Redwood Pharma participated in the BioStock Investor Meeting in September where CEO Martin Vidaeus presented the company’s work. Afterwards, BioStock had the chance to interview Vidaeus who told us more about Redwood Pharma’s projects RP501 and RP101, aimed at the treatment of dry eyes.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-intestor-meeting-interview-with-redwood-pharma/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Dignitana appoints Malin Isacsson to Head European Sales

Dignitana  announces that the Company has named Malin Isacsson as Vice President of Sales Europe. She begins her role immediately at the Company’s headquarters in Lund.  “Malin has proven success in solution sales for several leading MedTech companies in Europe and I am delighted that she has joined the Dignitana team. Her experience with both public and private healthcare are a valuable addition as we address the sales potential in markets across the EU and UK,” said Dignitana CEO Catarina Mård Löwenadler.  Most recently Malin worked at SoftPro Medical

Koselugo approved in Japan for NF1

27 September 2022 07:05 BST Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type 1 First medicine approved in Japan to treat this rare and debilitating genetic condition Pivotal SPRINT trial showed Koselugo reduced tumour volume Koselugo (selumetinib) has been approved in Japan for the treatment of paediatric patients three years of age and older with plexiform neurofibromas (PNs) in neurofibromatosis type 1 (NF1) with clinical symptoms, such as pain and disfigurement, and PNs which cannot be completely removed by surgery

The last day for trading in the warrants of series TO 5 in Idogen AB is today, September 27, 2022

Today, September 27, 2022, is the last day for trading in warrants of series TO 5 (“Warrants”) in Idogen AB (“Idogen” or the “Company”). The subscription period for the Warrants runs until September 29, 2022. Three (3) Warrants gives the right to subscribe for one (1) new share in Idogen at a subscription price of SEK 0.77 per share.   If all Warrants are exercised for subscription of shares, Idogen will receive approximately MSEK 25.4 before issue costs. In order for the Warrants not to lapse without value, the holder must actively subscribe for shares no later than September 29,

Metso Outotec introduces visionary NextGen Pelletizing[TM] plant concept supporting transition to green steel

Metso Outotec Corporation’s press release on September 27, 2022, at 09:00 a.m. EESTMetso Outotec is launching NextGen Pelletizing™, a visionary concept for the next generation of pelletizing plants that strive to be carbon-neutral and autonomous. This revolutionary concept is a part of the company’s Planet Positive  offering focused on environmentally efficient technologies. “NextGen Pelletizing™ is yet further proof of our strong commitment to building innovative pelletizing solutions that are sustainable

Impilo divests leading haemostatic device developer and manufacturer Ferrosan Medical Devices to Danish consortium of long-term investors

Impilo AB (“Impilo”) and other minority investors, incl. Hans-Christian Bødker Jensen, have signed an agreement to divest the Danish medical devices company Ferrosan Medical Devices Group A/S (“FeMD”) to a consortium of Danish long-term investors consisting of Kirk Kapital, Lundbeckfonden and ATP (the “Consortium”).Impilo invested in FeMD in 2017 and has together with the management team realised the vision of creating a world leading medical devices group with product innovation and improved health outcomes at the core of its business. During Impilo’s ownership, revenues and EBITDA have

Tezspire approved in Japan for severe asthma

27 September 2022 07:00 BST Tezspire approved in Japan for the treatment of severe asthma Tezspire approved for a broad population of patients with severe asthmawith no phenotype or biomarker limitations AstraZeneca's Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or refractory disease in whom asthma symptoms cannot be controlled with mid- or high-dose inhaled corticosteroids and other long-term maintenance therapies.[1] The approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) was based on

Storytel secures partnerships with leading publishers in France

Storytel, one of the world’s leading subscription services for audiobooks and e-books, has secured publishing deals with key French publishers such as Hachette Livre, Madrigall, Editis and Actes Sud. The agreements strengthen Storytel’s strategic focus on established audiobook markets and open the door for expansion into French-speaking markets. Storytel’s service in France is available from 27 September 2022. The service will offer a variety of subscription alternatives to meet the preferences of French consumers.Today, over two million subscribers across the world enjoy Storytel’s

Invitation to presentation of Essity’s Interim Report for the third quarter 2022

Essity’s Interim Report for the third quarter 2022 will be published on October 27 at approximately 07:00 CET. In conjunction with publication, a telephone and web presentation will be held at 9:00 CET where President and CEO Magnus Groth will present and answer questions.Presentation: Date: Thursday, October 27, 2022Time: 09:00 CETLink to Web presentation: https://essity.videosync.fi/2022-10-27-q3 Telephone: UK: +44 (0) 33 0551 0200, USA: +1 212 999 6659, SWE: +46 (0) 20 089 6377. Please call in well in advance of the start of the presentation. Indicate: "Essity Q3 Interim Report"

Swedbank launches a new Sustainable Funding Framework for green, social and sustainability bonds

The new framework is both an update of the 2017 Green Bond Framework and an expansion of the scope with social activities. With the framework, Swedbank is positioned to issue green, social and sustainability bonds promoting the UN Sustainable Development Goals. The framework is aligned with the ICMA Green Bond Principles 2021, Social Bond Principles 2021, and Sustainability Bond Guidelines 2021.– The new framework will enable us to further support our clients in the transition through financing green and social projects. It also supports Swedbank’s strategy of aligning the business to the

TIE Kinetix Signs Contract with Whole Earth Brands to Move Towards a 100% Cloud-Based Supply Chain

TIE Kinetix  announced today a new 5-year, $270,000 contract in the United States with Whole Earth Brands, a leading a global food company enabling healthier lifestyles and providing access to high-quality plant-based sweeteners, flavor enhancers, and other foods. With their decision to upgrade towards TIE Kinetix's FLOW Partner Automation platform, Whole Earth Brands has chosen to move 100% to the cloud and bring their supply chain solution to the next level.The upgrade towards the FLOW Partner Automation platform enables Whole Earth Brands to optimize their supply

Share buy-backs in Telia Company during week 38 2022

Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased own shares (ISIN: SE0000667925) as specified in the table below. The share buy-backs form part of the SEK 5.4 billion share buy-back program that Telia Company announced on June 1, 2022 . The share buy-back program is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”)

NCC to construct 144 new prison places in Mariestad

On behalf of Specialfastigheter, NCC will conduct the initial works for construction of new prison places at the Rödjan prison in Mariestad. The assignment will take place under the parties’ strategic partnering agreement, and planning and design will commence immediately. The potential order value of the contract is approximately SEK 900 million. Genre image: NCC “We are extending our partnership with Specialfastigheter and bringing our broad experience of the complex environments and critical social infrastructure required by the prison system. By working in the same team on all

Picadeli and Stora Enso won a Pentaward for their work in sustainable design

Picadeli’s new plastic-free lid in molded fiber has been awarded by Pentawards, a leading international competition in packaging design. Picadeli won in the sustainable design category for their plastic and PFAS-free product, which is also renewable, recyclable, biodegradable, and reduces plastic waste by approximately 120 tons per year. The lid was developed in collaboration with Stora Enso. The winners of the prestigious design competition Pentawards have been determined. Picadeli and Stora Enso were awarded a bronze statuette for their new salad lid in the sustainable design category.

Quantum technology reaches unprecedented control over captured light

[Illustration of the aluminum resonator to the right The blue and red patterns show quantum mechanical states that the Chalmers researchers can create and control Counting from the top to the bottom right the states are GottesmanKitaevPreskill GKP Cubic phase state Binomial state Fock state and Cat state Credit Yen Strandqvist Chalmers ] Researchers in quantum technology at Chalmers University of Technology have succeeded in developing a technique to control quantum states of light in a three-dimensional cavity. In addition to creating previously known states, the researchers are the

Trind VC raises new €55M fund to invest in consumer and SME-focused startups in Europe

With a team of experienced ex-founders and business angels, Trind VC is going to invest into 30–40 startups, putting more emphasis on cross-border investments in the Northern European startup ecosystem.HELSINKI, Finland (September 27th, 2022) Trind VC , a seed-stage venture fund based in Tallinn with team members in Helsinki and Munich, has announced closing of its €55M second fund. Trind VC aims to invest into 30–40 startups with proven traction in four years. The fund is backed by institutional investors such as European Investment Fund, Tesi (Finnish Industry

Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA

· The US Food and Drug Administration (FDA) has reviewed and accepted the protocol for the ONCOS-102 phase 2 combination trial in PD-1 checkpoint inhibitor (CPI) refractory advanced melanoma · The study is on track to start in late 2022 or early 2023Oslo, Norway, 27 September 2022 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target solid tumors, today announces that the FDA has accepted the protocol and given the formal go-ahead to proceed with the planned ONCOS-102 phase 2 trial in melanoma. Study initiation activities are

There are no items matching the current filter
There are no more items matching the current filter
Back to top